# Senti Biosciences Holdings, Inc. (SNTI) · Edgar & Edgarette company card

> Senti Biosciences Holdings (SNTI) reported revenue of $0 million in FY2025, operating margin -312632% against a -15.8% median for biological products, (no diagnostic substances), equity 10.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1854270 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/SNTI) · [JSON](https://www.pops4.com/boards/company/SNTI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $22,000 |
| Revenue growth, 1 year | — |
| Revenue growth per year | -70.1% |
| Operating margin | -312631.8% (prior year -Infinity%) |
| Net margin | -279263.6% |
| Operating cash flow | −$43M |
| Capital spending | $196,000 |
| Free cash flow | −$44M |
| Cash | $16M |
| Long-term debt | — |
| Total assets | $51M |
| Total equity | $6M |
| Equity ÷ assets | 10.9% |
| Return on equity | -1099.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -30.52 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Old boat · three warning signs · operating cash flow was negative (-$43.4M in FY2025); operating loss: a margin of -312631.8% in FY2025; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $22K (FY2025). Experience: one year on record, down 70.1% a year over 4 years; operating margin -312631.8%, up from null. Soundness: equity 10.9% of assets, return on equity -1099.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $3K and $5K next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (31 filers, $50M+ revenue, biological products, (no diagnostic substances)): operating margin -312631.8% against a -15.8% median.

Range logged 2026-09-20, receipt 943c16424b158772, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 1, latest 2026-09-02 ([filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026060124/0001628280-26-060124-index.htm))
- Item 5.02 Director or officer change: 2, latest 2026-10-27 ([filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026067624/0001628280-26-067624-index.htm))

## Recent filings

- 8-K · filed 2026-10-27 · 5.02 Departure or Election of Directors; Appointment of Officers; 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026067624/0001628280-26-067624-index.htm)
- 8-K · filed 2026-10-26 · 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000114036126040772/0001140361-26-040772-index.htm)
- 8-K · filed 2026-10-15 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026065992/0001628280-26-065992-index.htm)
- 8-K · filed 2026-10-13 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026065685/0001628280-26-065685-index.htm)
- 8-K · filed 2026-09-24 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026063369/0001628280-26-063369-index.htm)
- 8-K · filed 2026-09-04 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1854270/000162828026060600/0001628280-26-060600-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001854270.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1854270

## Cite

POPS4, Edgar & Edgarette: Senti Biosciences Holdings, Inc. (SNTI) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SNTI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.